Buprenorphine Hydrochloride and Naloxone Hydrochloride
- Generic Name
- Buprenorphine Hydrochloride and Naloxone Hydrochloride
- Indication
用于治疗鸦片类药物成瘾的患者。
Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
Phase 3
Completed
- Conditions
- Opioid DependenceOpioid Related Disorders
- Interventions
- First Posted Date
- 2015-02-06
- Last Posted Date
- 2018-02-20
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 665
- Registration Number
- NCT02357901
- Locations
- 🇺🇸
Comprehensive Clinical Research, Berlin, New Jersey, United States
🇺🇸Louisiana Clinical Research, Shreveport, Louisiana, United States
🇺🇸Stanley Street Treatment and Resources, Fall River, Massachusetts, United States
Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population
Phase 4
Completed
- Conditions
- Opioid Dependence
- Interventions
- First Posted Date
- 2014-01-17
- Last Posted Date
- 2017-03-21
- Lead Sponsor
- Indivior Inc.
- Target Recruit Count
- 33
- Registration Number
- NCT02038790
- Locations
- 🇺🇸
Hill Top Research, St Petersburg, Florida, United States
Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II)
Not Applicable
Completed
- Conditions
- Opiate Addiction
- Interventions
- First Posted Date
- 2009-06-29
- Last Posted Date
- 2022-05-27
- Target Recruit Count
- 170
- Registration Number
- NCT00929253
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Buprenorphine Naltrexone-P1 A-Cocaine
- First Posted Date
- 2008-08-13
- Last Posted Date
- 2017-01-12
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Target Recruit Count
- 8
- Registration Number
- NCT00733720
- Locations
- 🇺🇸
Drug Dependence Research Center, San Fransisco, California, United States
A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED)
Phase 4
Completed
- Conditions
- Opiate DependenceDrug DependenceSubstance Dependence
- Interventions
- First Posted Date
- 2008-01-30
- Last Posted Date
- 2017-07-02
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 188
- Registration Number
- NCT00604188
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath